Clark Capital Management Group Inc. Sells 17,250 Shares of Danaher Corporation $DHR

Clark Capital Management Group Inc. trimmed its holdings in Danaher Corporation (NYSE:DHR) by 7.1% in the third quarter, Holdings Channel reports. The institutional investor owned 225,541 shares of the conglomerate’s stock after selling 17,250 shares during the quarter. Clark Capital Management Group Inc.’s holdings in Danaher were worth $44,716,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the 2nd quarter valued at $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the 3rd quarter worth about $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the 3rd quarter worth about $28,000. Finally, Tripletail Wealth Management LLC bought a new position in Danaher in the 3rd quarter worth about $31,000. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 11.20% of the company’s stock.

Danaher Trading Up 0.6%

Shares of DHR opened at $187.34 on Monday. The firm’s 50 day simple moving average is $218.79 and its 200 day simple moving average is $215.48. The company has a market capitalization of $132.47 billion, a P/E ratio of 37.17, a P/E/G ratio of 2.54 and a beta of 0.93. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.14 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Leerink Partners raised their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $253.55.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.